1 September 2024
Quarterly Cashflow Report - March 2011
Melbourne, Australia; – Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today released its Appendix 4C – Quarterly Cash Flow Report for the quarter ended 31 March 2011.
The cash balance at 31 March 2011 was $20.1m compared to $19.7m at 31 December 2010.
The Operating & Investing cash outflow of $1.6m for the quarter includes the costs of the fully enrolled phase 2 study assessing VivaGel® as a treatment for bacterial vaginosis. Financing cash inflows of $2.0m included proceeds from the exercise of share options during the quarter.
Download ASX Announcement: Appendix 4C - March 2011 ( pdf file, 153kb)